U.S Class(es): 100, 101
Class Status: Active
First Use: Mar-04-2024
First Use in Commerce: Mar-04-2024
| Name | Christopher Bolinger Astellas Pharma Inc. |
|---|---|
| Address | 2375 Waterview Drive Trademarks Department Northbrook, IL 60602 United States |
| Date | Description | Action Tags | Code |
|---|---|---|---|
| Mar-14-2024 | NEW APPLICATION ENTERED | NWAPI | |
| Jun-05-2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | NWOSI | |
| Jun-05-2024 | NOTICE OF DESIGN SEARCH CODE E-MAILED | MDSCE | |
| Aug-30-2024 | ASSIGNED TO EXAMINER | DOCKD | |
| Sep-03-2024 | NON-FINAL ACTION WRITTEN | CNRTR | |
| Sep-03-2024 | NON-FINAL ACTION E-MAILED | GNRTF | |
| Sep-03-2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED | GNRNO | |
| Nov-25-2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED | TROAI | |
| Nov-25-2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE | CRFAI | |
| Nov-25-2024 | TEAS/EMAIL CORRESPONDENCE ENTERED | TEMEI | |
| Nov-26-2024 | APPROVED FOR PUB - PRINCIPAL REGISTER | CNSAO | |
| Dec-18-2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | NONPE | |
| Dec-24-2024 | PUBLISHED FOR OPPOSITION | PUBOA | |
| Dec-24-2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | NPUBE | |
| Feb-11-2025 | REGISTERED-PRINCIPAL REGISTER | R.PRA | |
| Feb-11-2025 | NOTICE OF REGISTRATION CONFIRMATION EMAILED | NRCCE | |
| Apr-10-2025 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | REAPI | |
| Apr-10-2025 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | ARAAI | |
| Apr-10-2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED | TCCAI |